CommentaryPublished 19 Feb 2021

Impact of fingolimod on multiple sclerosis

Authors: Gowthami Bainaboina

Journal of Multiple Sclerosis

Volume 8 · Issue 2 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The effectiveness of fingolimod on clinical and magnetic resonance imaging (MRI) outcomes in patients with multiple sclerosis (MS) has been well established in trials and, to a lesser extent, in the real world

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Multiple Sclerosis.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Multiple Sclerosis
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Gowthami Bainaboina”